Sorafenib case: the alleged legal presumption of validity of the patent admits evidence to the contrary in injunctive relief proceedings
[et_pb_section fb_built=”1″ _builder_version=”3.19.5″][et_pb_row _builder_version=”3.0.48″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”2_5″ _builder_version=”3.0.47″ parallax=”off” parallax_method=”on”][et_pb_image src=”https://vidalquadrasramon.com/wp-content/uploads/2022/10/drugs-2.jpg” _builder_version=”3.19.5″][/et_pb_image][/et_pb_column][et_pb_column type=”3_5″ _builder_version=”3.0.47″ parallax=”off” parallax_method=”on”][et_pb_post_title comments=”off” featured_image=”off” _builder_version=”3.19.5″ title_level=”h4″ title_font=”||||||||”][/et_pb_post_title][et_pb_text _builder_version=”3.19.5″] In this brief note we refer to the Order of the Barcelona Provincial Court (15th Section) 59/2022 of 22 April, which confirmed the Order of the Barcelona Commercial Court No. 1 of …
SPC manufacturing waiver: ten essential tips
On 2 July 2022, the SPC manufacturing waiver, approved by EU Regulation 2019/933, came into effect. This regulation is one of the most important initiatives developed in Europe for the pharmaceutical industry that manufactures its products in the European Union. To understand the importance of this regulation, we must take into account that 24% of …
INSIGHTS
Unfair Competition
The use of protective writs in unfair competition cases in Spain
Patents, Unfair Competition
The intersection between competition law and patent law: the fingolimod case
General, Industrial Property, VQR
